To examine the exquisite regulation of IgE-FcεRI tyrosine phosphorylation by Lyn kinase that is stimulated by antigen-mediated crosslinking, we utilized coexpression of FcεRI and Lyn in Chinese hamster ovary (CHO) cells that results in high basal levels of Lyn kinase activity and spontaneous phosphorylation of FcεRI. We find that co-expression of a lipid raft-excluded transmembrane tyrosine phosphatase, PTPα, suppresses Lyn kinase activity and markedly reduces the level of spontaneous phosphorylation of FcεRI, while facilitating its antigen-stimulated phosphorylation. Other tyrosine phosphatases, including SHP-1, CD45, and a lipid raft-preferring chimeric version of PTPα fail to reconstitute antigen-dependent FcεRI phosphorylation. We conclude that both substrate specificity and submembrane location are critical to phosphatasemediated regulation of Lyn kinase activity that supports activation of FcεRI.
INTRODUCTION
FcεRI, the high affinity receptor for IgE, is a member of the family of multichain immune recognition receptors (MIRR) including T cell and B cell receptors for antigen, certain NK cell receptors, and other Fc receptors on various hematopoietic cells. All of these receptors contain at least one ITAM or ITIM sequence in the cytoplasmic segment of one or more subunit (1, 2) . In every case, receptor-mediated signaling is initiated when tyrosine residues in these sequences are phosphorylated by a Src family tyrosine kinase. For FcεRI in mast cells, ITAM phosphorylation of both its β and γ 2 subunits is catalyzed principally by the Src kinase Lyn, and this is stimulated by antigen-mediated crosslinking of two or more IgE-receptor complexes (3, 4) . ITAM phosphorylation of this and other MIRR family members recruits and activates the tyrosine kinase Syk (or Zap70 in T cells), leading to a cascade of downstream signaling and cell activation processes (5, 6) .
The mechanism by which IgE-FcεRI crosslinking initiates receptor tyrosine phosphorylation has been extensively studied. The β subunit of FcεRI has been shown to bind Lyn weakly in the absence of ITAM phosphorylation (7) , and a transphosphorylation model has been developed from this and other studies (3) . In
To understand the role of lipid rafts in FcεRI phosphorylation by Lyn, we investigated the effects of this ordered lipid environment on Lyn tyrosine kinase activity in RBL mast cells. We found that rafts protect the active site tyrosine residue of Lyn from dephosphorylation, thereby enhancing the specific activity of Lyn kinase in lipid rafts relative to that in more disordered regions of the plasma membrane (13) . As crosslinking of IgE-FcεRI causes association of these receptors with lipids rafts (10, 14) , we postulated that the raft environment serves principally to permit receptor phosphorylation by active Lyn in the same environment and to protect these proteins from dephosphorylation by a phosphatase that is excluded from lipid rafts (13) .
To test this hypothesis, we utilized FcεRI stably expressed in a CHO cell line that exhibits an unusually high level of basal (unstimulated) FcεRI tyrosine phosphorylation due to co-expressed Lyn (15) . We compared the capacity of different tyrosine phosphatases to regulate both basal and stimulated FcεRI tyrosine phosphorylation in this situation. We find that expression of the transmembrane phosphatase PTPα is highly effective in this role. Furthermore, we show that conversion of PTPα to a lipidanchored, raft-preferring phosphatase abolishes its capacity to facilitate antigenstimulated FcεRI tyrosine phosphorylation. Our results are consistent with a general role for protein segregation by lipid rafts in the regulation of enzymatic and other signaling processes.
EXPERIMENTAL PROCEDURES
DNA constructs -Lyn was amplified by PCR from Lyn-pcDM8, provided by Dr. Henry Transfections -CHO cells stably transfected with FcεRI (CHO-FcεRI cells) (16) were transiently transfected in 6-well plates using Geneporter (GTS, San Diego, CA): for each well, 10 µl Geneporter and 1 µg of Lyn-pcDNA3 and 1 µg phosphatase construct DNA (or 0.5 µg of PM-PTPα and 0.5 µg pcDNA3), or equivalent amounts of empty pcDNA3 vector for controls, were added to 100 µl Optimem (Invitrogen, Grand Island, NY), incubated for 15 minutes and added to cells plated over with 1 ml Optimem, then incubated for 6 hours at 37°C with 5% CO 2 , and finally washed and plated with CHO medium containing 1 µg/ml mouse IgE.
Antibodies -Mouse IgE specific for DNP-BSA was prepared as previously described (Posner et al. 1992 ). Antibodies used include: mouse anti-Lyn H6 mAb and polyclonal rabbit anti-Lyn 44 (Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-phosphotyrosine mAb (4G10) and rabbit anti-SHP-1 (Upstate Biotechnology, Lake Placid, NY), mouse anti-CD45 mAb (GAP8.3 (ATCC), rabbit anti-pY508 (anti-phospho-Lyn (Y507) (Cell Signaling Technologies, Beverly, MA), rabbit anti-IgE (17) , and FITC-goat antimouse IgG2a (Southern Biotechnology, Birmingham, AL)
Examination of phosphorylation -To examine whole cell tyrosine phosphorylation, transfected CHO-FcεRI cells, or RBL-2H3 cells (18) , were suspended at 2x10 6 cells/ml in buffered saline solution (BSS (11)) containing bovine serum albumin (Sigma) and equilibrated to 37°C. Cells were lysed with non-reducing SDS sample buffer before and after 2 or 5 minutes of stimulation with 0.9 µg/ml DNP-BSA (14) . Samples were separated by electrophoresis on 12% acrylamide SDS gels and quantitative immunoblotting was performed as previously described (13) . For immunoprecipitation of FcεRI, cells were suspended at 8 x 10 6 cells/ml and lysed in RIPA buffer (0.5% TX-100, 0.5% deoxycholate, 0.05% SDS), which has been shown to solubilize all membrane components (13) . Anti-IgE immunoprecipitations used 10 µg of anti-IgE for 0.5 ml of cell lysate, and immune complexes were pulled down with 35 µl of protein A beads (Pierce).
Determination of Lyn in vitro kinase activity from Lyn was immunoprecipitated with mouse anti-Lyn mAb from RIPA or TX-100 post nuclear supernatants of CHO-FcεRI cells using α-casein as the substrate was carried out as previously described (13) .
Measurement of in vitro phosphatase activity for expressed PTPα and PM-PTPα, anti-HA immunoprecipitated from CHO cell lysates, was carried out as previously described (41) . 
INSERT FIGURE 1 HERE
To investigate the basis for the high basal tyrosine phosphorylation observed in Lyn-transfected CHO cells, we more closely examined Lyn kinase. As a first step we immunoprecipitated Lyn kinase from these cells and from RBL cells and compared their specific activities using a-casein as previously described (13) . Figure 1B shows that Lyn kinase expressed in CHO cells has ~3-fold higher specific activity than Lyn from RBL cells, consistent with the higher levels of basal phosphorylation in the CHO-FcεRI cells.
Lyn kinase activity is positively regulated by phosphorylation near its active site, Tyr397 (Lyn A notation), and negatively regulated by phosphorylation on its C-terminal tail, Tyr508. Our previous study in RBL cells showed that Lyn activity is largely determined by phosphorylation at Tyr397, whereas C-terminal phosphorylation is very low in resting cells (13) . To assess the relative phosphorylation of these sites for Lyn in the CHO cells, we compared various Lyn mutants, using both 4G10 antiphosphotyrosine and an antibody specific for the phosphorylated C-terminus of Lyn (anti-pY508) by western blot analysis. As shown in Figure 1C , we find that wt Lyn Lyn expressed in CHO cells is hyperphosphorylated at Tyr397, and this is likely to account for its high specific activity.
Co-expression of protein tyrosine phosphatase PTPα with Lyn in CHO cells reconstitutes antigen-dependent FcεRI phosphorylation.
The large amount of Lyn-dependent basal phosphorylation in CHO cells suggests that these cells lack sufficient phosphatase activity to regulate exogenously expressed Lyn kinase. PTPα is a ubiquitously expressed transmembrane tyrosine phosphatase that has been found to regulate Src kinase activity (19) . 
Reconstitution of signaling in CHO cells is dependent on the location of PTP activity.
We showed in Figure 1 that Lyn expressed in CHO cells is highly active, most likely because it is strongly phosphorylated at its active site. Likewise, the activity of endogenous Lyn in RBL cells is controlled by phosphorylation at the active site (13) . In that study, we found that Lyn specific activity is substantially higher in lipid rafts than in disordered regions of the plasma membrane. We hypothesized that rafts exclude transmembrane phosphatases that dephosphorylate and thereby inactivate Lyn located outside of lipid rafts. In Figure 3A , Lyn expressed in CHO cells is highly active (Fig. 1B) , and we next examined if the effects of PTPα on whole cell phosphorylation are mediated through control of Lyn activity. Figure 3C compares the specific activities of Lyn solubilized and immunoprecipitated from CHO cells with or without PTPα or PM-PTPα co-expressed.
PTPα causes a substantial decrease in specific activity of Lyn. This reduction in Lyn kinase activity may be sufficient to account for the control of basal FcεRI phosphorylation in CHO cells expressing exogenous Lyn. The specific activity of Lyn solubilized from CHO-FcεRI cells co-expressing Lyn and PM-PTPα is more severely reduced than that with PTPa (Fig. 3C) . This further reduction in activity correlates with a reduction of Lyn activity regardless of its raft environment in PM-PTPα transfected cells, consistent with the dephosphorylation of Lyn at its active site tyrosine by PM-PTPα in both the raft and non-raft environment. Because PM-PTPα co-localizes with Lyn in lipid rafts, it has continual access to this substrate, whereas transmembrane PTPα is restricted to nonraft portions of the plasma membrane and is unable to inactivate raft-associated Lyn.
Effects of other PTPs on FcεRI phosphorylation by Lyn in CHO cells.
To ascertain the selectivity of PTPα regulation of FcεRI phosphorylation by Lyn, we compared its effects to those of two other tyrosine phosphatases, SHP-1 and CD45.
SHP-1 is a hematopoietic phosphatase shown to negatively regulate MIRR signaling, including FcεRI signaling in mast cells (22. 23) . It is located primarily in the cytoplasm, but it is recruited to the plasma membrane during antigen stimulation (22) . Figure 4A shows a representative experiment in which co-expression of SHP-1 with Lyn in CHOFcεRI cells is compared to co-expression of PTPα. SHP-1 efficiently inhibits Lyn autophosphorylation and suppresses FcεRI stimulation, both before and after stimulation, reminiscent of the effects of PM-PTPα (Fig. 3B ). Active SHP-1 binds to protein substrates via its SH2 domains and is probably not restricted from Lyn in lipid rafts. In contrast, expression of CD45 in CHO cells causes small increases in tyrosine phosphorylation levels of multiple cellular proteins, including Lyn and FcεRI, both before and after stimulation (Fig 4B) . Because CD45 is difficult to detect by immunoblotting, we used flow cytometry analysis that showed relatively low levels of CD45 in transfected CHO cells compared to the highly abundant expression of this phosphatase on Jurkat T cells (data not shown). Like PTPα, CD45 is a type 1 transmembrane protein that is excluded from lipid rafts (24) , so it is unlikely that its plasma membrane location distinguishes its effects from those of PTPα. CD45 is often implicated in positive regulation of immune cell signaling by dephosphorylation of the C-terminal negative regulatory tyrosine of Src family kinases such as Lck (25) , and our results are consistent with this role.
INSERT FIGURE 4 HERE
To investigate the mechanism by which CD45 expression leads to an increase in basal phosphorylation in CHO-FcεRI cells we compared tyrosine phosphorylation of Lyn expressed in the presence or absence of PTPα, SHP-1 or CD45. Figure 4C summarizes the quantitative comparisons for both total tyrosine phosphorylation and Tyr508 phosphorylation, normalized separately to equivalent amounts of Lyn. We find that PTPα and SHP-1 both dephosphorylate Lyn exclusively at Tyr397, and that SHP-1 expression actually leads to an increase in Tyr508 phosphorylation through an unknown mechanism. In contrast, CD45 expression results in a small net dephosphorylation of Lyn at Tyr508 that can account for the modest increase in cellular tyrosine phosphorylation we observe in CD45 expressing CHO cells (Fig. 4B) . Thus, among these three phosphatases, only PTPα has the necessary combination of plasma membrane location (exclusion from lipid rafts) and substrate specificity (Lyn Tyr397) that allow it to reconstitute effective regulation of Lyn kinase activity and the early events of FcεRI signaling in CHO cells.
DISCUSSION
Our present findings show that a transmembrane tyrosine phosphatase, PTPα, plays an essential role in the regulation of FcεRI phosphorylation by Lyn when this kinase and receptor are co-expressed in CHO cells. Lyn expressed in CHO cells has a substantially higher specific activity than Lyn in RBL cells due to high levels of phosphorylation at its active site Tyr397 (Fig. 1) . Enhanced Lyn kinase activity in the CHO cells leads to spontaneous phosphorylation of multiple cellular proteins, including FcεRI (Fig 1) . Co-expression of PTPα results in marked dephosphorylation of Lyn in these cells, thereby suppressing basal phosphorylation of several substrates while enabling stimulated phosphorylation of FcεRI (Fig. 2) .
Our previous studies revealed that active Lyn in RBL mast cells is largely sequestered in lipid rafts, and this Lyn is active due to phosphorylation at its active site (13) . In light of this, we investigated whether segregation of Lyn from a transmembrane phosphatase by lipid rafts is important for the regulation of Lyn activity. CHO-FcεRI cells provide a useful vehicle to test this possibility because Lyn in these cells is less effectively regulated than in RBL cells. We determined that PTPα is excluded from lipid rafts, and thus is unable to gain access to and inactivate Lyn within the ordered raft environment. In clear contrast, targeting chimeric PM-PTPα to lipid rafts abolishes stimulation-dependent FcεRI phosphorylation by inactivating Lyn both within and outside of the raft environment (Fig. 3) . These results support a model in which lipid rafts act both to protect Lyn from phosphatases, which keeps raft-associated Lyn active, and to inhibit productive interactions of FcεRI with active Lyn until crosslinking by multivalent antigen brings them together by driving raft association of FcεRI. Crosslinking FcεRI in this manner may also serve to stabilize ordered membrane domains containing active Lyn.
Metzger and colleagues have argued against a role for lipid rafts in protecting
FcεRI from dephosphorylation in studies that utilized the reversal of antigen crosslinking by monovalent hapten to observe rapid dephosphorylation of FcεRI and other phosphorylation substrates (26, 27) . However, reversal of crosslinking causes a rapid In contrast, CD45 is largely excluded from lipid rafts (24), like PTPα, but its expression in CHO cells causes small increases in spontaneous and stimulated FcεRI phosphorylation (Fig. 4) . We find that CD45 preferentially dephosphorylates Lyn at its negative regulatory site, Tyr508, which likely leads to an increase in Lyn activity, causing enhanced FcεRI phosphorylation. This suggests that CD45 is primarily a positive regulator of Lyn activity, in agreement with evidence showing that high levels of CD45 expression in RBL cells leads to increased degranulation following antigen stimulation (34) . Previous studies showed that CD45 is not required for FcεRI signaling in RBL mast cells (35, 36) , and our results are consistent with these findings.
In other studies, expression of lipid raft-targeted chimeric phosphatases from either SHP-1 or CD45 were used to investigate the role of tyrosine phosphatase segregation from lipid rafts in T cell receptor signaling (37) (38) (39) . All of these studies reported inhibition of downstream signaling due to the raft-targeted chimeric phosphatases, and, in one study, inhibition of stimulated receptor phosphorylation was observed (39) . These studies, together with our results, suggest that exclusion of membrane associated tyrosine phosphatases from the ordered lipid environment of lipid rafts may be a general mechanism for the regulation of immunoreceptor signaling. 
